Search Results - "Brennan, Joy"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    The Three Natures and the Path to Liberation in Yogācāra-Vijñānavāda Thought by Brennan, Joy Cecile

    Published in Journal of Indian philosophy (01-09-2018)
    “…This paper provides a new interpretation of the three natures theory of Yogācāra-Vijñānavāda thought by means of an examination of the path theory associated…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    High Readmission Rates Are Associated with a Significant Economic Burden and Poor Outcome in Patients with Grade 3/4 Acute GvHD by Dignan, Fiona L, Potter, Michael N, Ethell, Mark E, Brennan, Joy, McNamara, Louise, Evans, Stephen O, Dearden, Claire E., Davies, Faith E, Morgan, Gareth J, Shaw, Bronwen E.

    Published in Blood (18-11-2011)
    “…Abstract 2061 The impact of graft versus host disease (GvHD) on readmission rates following allogeneic stem cell transplantation (SCT) has not been reported…”
    Get full text
    Journal Article
  5. 5

    Like a lotus in muddy water: Achieving purity in an impure world according to the Yogacara-Vijnanavada three natures theory by Brennan, Joy Cecile

    Published 2015
    “…This dissertation argues that the three natures theory in early and middle period Yogācāra-Vijñānavāda thought in India and China grapples with a paradox that…”
    Get full text
    Dissertation
  6. 6
  7. 7

    Duration of Initial Admission and Subsequent Readmission in the First 100 Days Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation by Dungarwalla, Moez, Brennan, Joy, Kulkarni, Samar, Saso, Radovan, Shaw, Bronwen, Jennifer, Treleaven G., Claire, Dearden E., Gareth, Morgan J., Mark, Ethell E., Mike, Potter N.

    Published in Blood (16-11-2007)
    “…Allogeneic stem cell transplantation (allo-SCT) after a reduced intensity conditioning (RIC) protocol is associated with decreased transplant related organ…”
    Get full text
    Journal Article
  8. 8

    Incidence of Second Malignant Neoplasms (SMN) after Haematopoetic Stem Cell Transplant by Kulkarni, Samar, Potter, Michael, Ethell, Mark, Saso, Radovan, Treleaven, Jennifer, Brennan, Joy, Kaczmarek, Pawel, Hiwarkar, Prashant, Kanagasabapathy, Pamala, Alvares, Caroline, Horton, Clive, Powles, Raymond, Saran, Frank, Morgan, Gareth

    Published in Blood (16-11-2006)
    “…From August 1973 to December 2003, 1651 patients (median age: 28yr., range: 1–74 yr.; M: 982, F: 669) received stem cell transplants for haematological…”
    Get full text
    Journal Article
  9. 9

    Lymphocyte Count on Day 56 Predicts for Reduced Risk of Infection Related Mortality Following Non-Myeloablative Allogeneic Haematopoietic Stem Cell Transplantation by Alvares, Caroline, Kulkarni, Samar, Kaczmarek, Pawel, Saso, Radovan, Woods, Helena, Brennan, Joy, Horton, Clive, Treleaven, Jennifer, Ethell, Mark, Dearden, Claire, Morgan, Gareth, Potter, Michael

    Published in Blood (16-11-2006)
    “…In vivo T-cell depletion using Alemtuzumab containing conditioning regimens are commonly employed in high risk patients undergoing non-myeloablative allogeneic…”
    Get full text
    Journal Article
  10. 10

    Pregnancy Outcome Following Haematopoietic Stem Cell Transplantation by Kulkarni, Samar, Ethell, Mark, Treleaven, Jennifer, Saso, Radovan, Brennan, Joy, Kaczmarek, Pawel, Alvares, Caroline, Horton, Clive, Saran, Frank, Kanagasabapathy, Pamala, Hiwarkar, Prashant, Appiah-Cubi, Stella, Dungarwala, Moez, Powles, Raymond, Morgan, Gareth, Potter, Michael

    Published in Blood (16-11-2006)
    “…Between March 1973 and August 2003, 747 patients (M: 430, F:317; median age: 29yr, range:1–65) who survived for at least 1 yr. post stem cell transplant and…”
    Get full text
    Journal Article